Apogee Therapeutics
Organization
Apogee Therapeutics is a clinical-stage biotechnology company focused on developing differentiated biologics for the treatment of immunological and inflammatory disorders. The company's pipeline targets conditions with high unmet needs, including atopic dermatitis, chronic obstructive pulmonary disease (COPD), and asthma.
2 episodes featuring Apogee Therapeutics
Stock Movers
AbbVie targets Apogee in eleven billion dollar deal as Regenxbio advances
Major pharmaceutical acquisitions and shifting regulatory pathways are rapidly redefining valuations in the biotechnology sector.
Jun 22, 2026 · 6 min
Stock Movers
Acquisition rumors and major AI alliances spark pre-market stock surges
This episode highlights how strategic acquisitions and artificial intelligence partnerships are rapidly reshaping valuations in traditional and tech sectors alike.
Jun 22, 2026 · 6 min